Patient Journey
How We Can Help
Utilizing real-world data (RWD), MMIT provides comprehensive insights into the patient journey, from early diagnosis to treatment completion. By integrating lab, claims, EHR, and payer data, we help pharmaceutical companies identify and engage patients earlier, understand treatment behaviors, and remove access barriers effectively.
Identify patients and their treating providers earlier in the patient journey, even for rare conditions that don’t have an ICD-10 code.
Understand the true prevalence of rare and hard-to-diagnose conditions, and hyper-segment patients using clinical notes, lab results and other real-world data.
Identify and target high-value physicians using the earliest qualifying patient event like diagnostic testing or symptom documentation.
See why treatments start, stop, or switch—based on what physicians document about adverse events, symptom severity, and patient response.
Leverage physician notes and switching behavior to understand how your product is perceived versus competitors—directly from real-world encounters.
Correlate treatment behavior with HCP sentiment, payer coverage, and site-of-care trends to inform your pull-through strategy.